Pleural sclerosis for the treatment of pneumothorax and pleural effusion

Lung

Volumn 175, Issue 4, 1997, Pages 213-223

  Light, R W ^a   Vargas, F S ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Pleural effusion; Pleurodesis; Pneumothorax; Talc; Tetracycline

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; DOXYCYCLINE; HYDROCHLORIC ACID; IMMUNOMODULATING AGENT; MEPACRINE; MINOCYCLINE; MITOXANTRONE; PICIBANIL; SCLEROSING AGENT; SODIUM HYDROXIDE; TALC; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

CLINICAL TRIAL; HUMAN; INTRAPLEURAL DRUG ADMINISTRATION; PLEURA EFFUSION; PLEURODESIS; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY FAILURE; REVIEW; SPONTANEOUS PNEUMOTHORAX; THORACOSCOPY; THORAX PAIN; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

ADJUVANTS, IMMUNOLOGIC; ANTINEOPLASTIC AGENTS; HUMANS; PLEURAL EFFUSION; PLEURODESIS; PNEUMOTHORAX; SCLEROSING SOLUTIONS; TALC; TETRACYCLINES;

EID: 0030912639     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007568     Document Type: Review

References (55)

1. Alfageme I, Moreno L, Huetas C, Vargas A, Hernandez J, Beizteggui A (1994) Spontaneous pneumothorax: long-term results with tetracycline pleurodesis. Chest 106:347-350
2. Almind M, Lange P, Viskum K (1989) Spontaneous pneumothorax: comparison of simple drainage, talc pleurodesis, and tetracycline pleurodesis. Thorax 44:627-630
3. Ariel IM, Oropeza R, Pack GT (1966) Intracavitary administration of radioactive isotopes in the control of effusions due to cancer. Cancer 19:1096-1101
4. Austin EH, Flye MW (1979) The treatment of recurrent malignant pleural effusion. Ann Thorac Surg 28:190-203
5. Bouchama A, Chastre J, Gaudichet A, Soler P, Gibert C (1989) Acute pneumonitis with bilateral pleural effusion after talc pleurodesis. Chest 86:795-797
6. Brunner RG, Vinsant GO, Alexander RH, Laneve L, Fallon WF Jr (1990) The role of antibiotic therapy in the prevention of empyema in patients with an isolated chest injury (ISS 9-10): a prospective study. J Trauma 30:1148-1153
7. Dusmet M, Winton TL, Kesten S, Maurer J (1996) Previous intrapleural procedures do not adversely affect lung transplantation. J Heart Lung Transplant 15:249-254
8. Groth G, Gatzemeier U, Haubingen K, Heckmayr M, Magnussen H, Neuhauss R, Pavel JV (1991) Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone vs placebo (pleural tube alone). Ann Oncol 2:213-215
9. Heffner JE, Standerfer RJ, Torstveit J, Unruh L (1994) Clinical efficacy of doxycycline for pleurodesis. Chest 105:1743-1747
10. Hurewitz AN, Lidonicci K, Wu CL, Reim D, Zucker S (1994) Histologic changes of doxycycline pleurodesis in rabbits. Chest 106:1241-1245
11. Izbicki R, Weyhing BT, Baker L, et al. (1975) Pleural effusion in cancer patients: a prospective randomized study of pleural drainage with the addition of radioactive phosphorus to the pleural space vs pleural drainage alone. Cancer 36:1511-1518
12. Kataoka M, Morishita R, Hiramatsu J, Ueoka H, Nakata Y, Ohnoshi T, Kimura I, Harada M (1995) OK-432 induces production of neutrophil chemotactic factors in malignant pleural effusion. Intern Med 34:352-356
13. Kennedy L, Harley RA, Sahn SA, Strange C (1995) Talc slurry pleurodesis: pleural fluid and histologic analysis. Chest 107:1707-1712
14. Kennedy L, Rusch VW, Strange C, Ginsberg RJ, Sahn SA (1994) Pleurodesis using talc slurry. Chest 106:342-346
15. Kennedy L, Sahn SA (1994) Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest 106:1215-1222
16. Kinsey DL, Carter D, Klassen KP (1964) Simplified management of malignant pleural effusion. Arch Surg 89:389-391
17. Leininger BJ, Barker WL, Langsten HT (1969) A simplified method for management of malignant pleural effusion. J Thorac Cardiovasc Surg 58:758-763
18. Light RW (1993) Management of spontaneous pneumothorax. Am Rev Respir Dis 148:245-248
19. Light RW (1995) Pleural Diseases. 3rd ed. Williams and Wilkins, Baltimore
20. Light RW, O'Hara VS, Moritz TE, McElhinney AJ, Butz R, Haakenson CM, Read RC, Sassoon CS, Eastridge CE, Berger R, Fontenelle LJ, Bell RH, Jenkinson SG, Shure D, Merrill W, Hoover E, Campbell SC (1990) Intrapleural tetracycline for the prevention of recurrent spontaneous pneumothorax. JAMA 264:2224-2230
21. Light RW, Wang N-S, Despars JA, Gruer SE, Sassoon CS, Vargas FS (1996) Experimental study comparing mitoxantrone and tetracycline as pleural sclerosing agents. Lung 174:373-38
22. Light RW, Wang N-S, Sassoon CSH, Gruer SE, Oliver D, Vargas FS (1995) Talc slurry is an effective pleural sclerosant in rabbits. Chest 107:1702-1706
23. Light RW, Wang N-S, Sassoon SCH, Gruer SE, Vargas FS (1994) Comparison of the effectiveness of tetracycline and minocydine as pleural sclerosing agents in rabbits. Chest 106:577-582
24. Lorch DG, Gordon L, Wooten S, et al. (1988) Effect of patient positioning on distribution of tetracycline in the pleural space during pleurodesis. Chest 93:527-529
25. Luh KT, Yang PC, Kuo SH, Chang DB, Yu CJ, Lee LN (1992) Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer: a randomized trial. Cancer 69:674-679
26. Maiche AG, Virkkunen P, Kontkanen T, Moykkynen K, Porkka K (1993) Bleomycin and mitoxantrone in the treatment of malignant pleural effusions. Am J Clin Oncol 16:50-53
27. Marchi E, Vargas FS, Teixeira L, Fagundes DJ, Silva LMMF, Carmo AO, Light RW (1996) Comparison of nitrogen mustard, cytarabine and dacarbazine as pleural sclerosing agents in rabbits. Eur Respir J, in press
28. McGovern JP, Xie CM, Vahdat O, Light RW (1996) The acute effects of three different talc products in an animal model. Am J Respir Crit Care Med 153:461 (abstr)
29. Milanez JRC, Vargas FS, Filomeno LTB, Fernandez A, Jatene A, Light RW (1994) Intrapleural talc for the prevention of recurrent pneumothorax. Chest 106:1162-1165
30. Milanez JR, Werebe EC, Light RW (1997) Respiratory failure due to insufflated talc. Lancet 349:251-252
31. Peng M-J, Kuo H-T, Chen P-J, Wu C-L, Lin F-J, Lin C-C (1995) Minocydine pleurodesis for malignant pleural effusions. Thorac Med 10:243-248
32. Petrou M, Kaplan D, Goldstraw P (1995) Management of recurrent malignant pleural effusions: the complementary role of talc pleurodesis and pleuroperitoneal shunting. Cancer 75:801-805
33. Rinaldo JE, Owens GR, Roger RM (1983) Adult respiratory distress syndrome following intrapleural instillation of talc. J Thorac Cardiovasc Surg 85:523-526
34. Rodriguez-Panadero F, Segado A, Martin Juan J, Ayerbe R, Torres Garcia I, Castillo J (1995) Failure of talc pleurodesis is associated with increased pleural fibrinolysis. Am J Respir Crit Care Med 151: 785-790
35. Rossi GA, Felletti R, Balbi B, Sacco O, Cosulich E, Risso A, Melioli G, Ravazzoni C (1987) Symptomatic treatment of recurrent malignant pleural effusions with intrapleurally administered Corynebacterium parvum. Am Rev Respir Dis 135:885-890
36. Rubinson RM, Bolooki H (1972) Intrapleural tetracycline for control of malignant pleural effusion: a preliminary report. South Med J 65:847-849
37. Sahn SA, Good JT (1981) The effect of common sclerosing agents on the rabbit pleural space. Am Rev Respir Dis 124:65-67
38. Sahn SA, Good JT Jr (1988) Pleural fluid pH in malignant effusions. Ann Intern Med 108:345-349
39. Sanchez-Armengol A, Rodriguez-Panadero F (1993) Survival and talc pleurodesis in melastatic pleural carcinoma, revisited: report of 125 cases. Chest 104:1482-1485
40. Sassoon CSH, Light RW, Vargas FS, Gruer SE, Wang N-S (1995) Temporal evolution of pleural fibrosis induced by intrapleural minocydine injection. Am J Respir Crit Care Med 151:791-794
41. Seaton KG, Patz EF Jr, Goodman PC (1995) Palliative treatment of malignant pleural effusions: value of small-bore catheter thoracostomy and doxycycline sclerotherapy. AJR 164:589-591
42. Sherman S, Ravikrishnan KP, Patel AS, et al. (1988) Optimum anesthesia with intrapleural lidocaine during chemical pleurodesis with tetracycline. Chest 93:533-536
43. Shinto RA, Stansbury DW, Brown SE, Light RW (1987) Does therapeutic thoracentesis improve the exercise capacity of patients with pleural effusion. Am Rev Respir Dis 135:244 (abstr)
44. Spector ML, Stern RC (1989) Pneumothorax in cystic fibrosis: a 26-year experience. Ann Thorac Surg 47:204-207
45. Strange C, Baumann MH, Sahn SA, Idell S (1995) Effects of intrapleural heparin or urokinase on the extent of tetracydine-induced pleural disease. Am J Respir Crit Care Med 151:508-515
46. Van de Brekel JA, Duurkens VAM. Vanderschueren RG (1993) Pneumothorax: results of thoracoscopy and pleurodesis with talc poudrage and thoracotomy. Chest 103:345-347
47. Vargas FS, Milanez JR, Filomeno LT, Fernandez A, Jatene A, Light RW (1994) Intrapleural talc for the prevention of recurrence in benign or undiagnosed pleural effusion. Chest 106:1771-1775
48. Vargas FS, Teixeira LR, Coelho IJC, Braga GA, Terra-Filho M, Light RW (1994) Distribution of pleural injectate: effect of volume of injectate and animal rotation. Chest 106:2146-1249
49. Vargas FS, Teixeira LR, Silva LMMF, Carmo AO, Light RW (1995) Comparison of silver nitrate and tetracycline as pleural sclerosing agents in rabbits. Chest 108:1080-1083
50. Vargas FS, Wang N-S, Lee HM, Gruer SE, Sassoon CSH, Light RW (1993) Effectiveness of bleomycin in comparison to tetracycline as pleural sclerosing agent in rabbits. Chest 104:1582-1584
51. Villanueva AG, Gray AW Jr, Shahian DM, Williamson WA, Beamis JF Jr (1994) Efficacy of short term vs long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions. Thorax 49:23-25
52. Viskum K, Lange P, Mortensen J (1989) Long term sequelae after talc pleurodesis for spontaneous pneumothorax. Pneumologie 43:105-106
53. Walker-Renard PB, Vaughan LM, Sahn SA (1994) Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 120:56-64
54. Weisberger AS, Bonte FJ, Suhrland LG (1956) Management of malignant serous effusions. Geriatrics 11:23-30
55. Zazenski R, Ashton WH, Briggs D, Chudkowski M, Kelse JW, MacEachern L, et al. Talc: occurrence, characterization, and consumer applications. Regul Toxicol Pharmacol 21:218-229